We are pleased to announce the CE approval on iRes™2, our fastest 2.0Khz excimer laser, empowering the smallest 350um laser micro-spot to execute iVis proprietary full automated, real-time controlled, no-touch, cTen® surgical procedure, maximizing surgical performance and avoiding intra-operative risks.
We are pleased to announce the CE approval on CIPTA®2, the unique cloud-based software conceived for interactive ray-tracing customized corneal surgical planning
We are pleased to announce the achievement of the CE mark on SafeCross®+ medical device on May 7th, 2021.
SafeCross®+ is a riboflavin ophthalmic solution, patented by iVis Technologies, granting high cross-linking efficiency in poor oxygen environment.
The 4D Suite™ is an integrated ensemble of hardware and software devices.
We are pleased to announce you that iVis 11th International Users’ meeting will be held in the form of a Webinar.
We are pleased to inform you that, on the 21st of February 2020, iVis Technologies received the CE Certification (awarded in compliance with the MDD 93/42/EEC European directive) for the commercialization of SafeCross™ medical device.
We are glad to announce you that iVis Technologies received the Innovation 4.0 second absolute award at the Fair of Automation & Testing in Turin
Advanced therapeutic applications planned remotely by Cipta proprietary planning software and using state-of-the-art iRes 1kHz Laser Platform for Corneal Refractive Surgery, Remote Controlled Laser treatments – high definition preoperative exams using Precisio2 Corneal Tomographer and pMetrics Pupillometer.
For one of its inventions, iVis was granted the European patent EP 1 649 843 which relates to a smart control of the surface power density of surgical laser systems which becomes more and more important in increasingly fast laser systems.
iVIS Technologies was granted the European patent EP 1 428 470 which relates to customized lamellar transplantations of corneal tissue for one of its early innovations. Such transplantations may be used to restore the vision of patients who suffer from corneal diseases such as keratokonus. A customized layer of the patient’s diseased cornea tailored according to patient’s needs is removed and replaced by a healthy layer of a donor cornea.